CoChat

The histopathological evaluation of drug‐induced liver injury

Kleiner, David E · 2017 · Histopathology
Cited by 52

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Drug‐induced liver injury (DILI) presents unique challenges to the pathologist. It is not only an uncommon reason for liver biopsy, but the pathology of DILI is spread across the entire spectrum of hepatic injury patterns. It is important for the pathologist to suspect DILI when the histological changes are unusual or out of synchronicity with the patient's history. A systematic evaluation approach will yield the most information. It begins with the characterization of the general pattern of injury which, for most cases, will be found in a handful of necroinflammatory and cholestatic patterns. A careful assessment of the severity of injury across the various anatomic compartments will provide information on the probable natural history of the injury. Correlation of liver injury with the patient's medication history and clinical findings will help to narrow the differential diagnosis, particularly when it is recognized that most drugs have a limited range of histological findings and vary in their propensity to cause injury. This review provides an overview of the assessment of the liver biopsy and its use to confirm or exclude particular drugs as contributing to the patient's liver injury.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/his.13082

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 58

  1. Food and Drug Administration, 2000, Withdrawal of troglitazone and cisapride, JAMA, 283, 2228, 10.1001/jama.283.17.2228 · doi:10.1001/jama.283.17.2228
  2. 10.1016/j.cct.2006.04.005 · DOI
  3. 10.1053/jhep.2002.34857 · DOI · Paper page
  4. 10.1001/archinte.1965.03860140008003 · doi:10.1001/archinte.1965.03860140008003
  5. 10.1002/hep.26709 · DOI · Paper page
  6. 10.1016/S0016-5085(19)32568-5 · DOI · Paper page
  7. 10.1042/cs0720263 · DOI · Paper page
  8. 10.1002/hep.27157 · DOI · Paper page
  9. 10.1002/hep.23588 · DOI · Paper page
  10. 10.1002/hep.24481 · DOI · Paper page
  11. 10.1016/j.cgh.2016.05.043 · DOI · Paper page
  12. 10.1136/jcp.56.11.850 · doi:10.1136/jcp.56.11.850
  13. 10.1111/j.1365-2559.1994.tb01321.x · DOI
  14. 10.1093/ajcp/74.4.442 · DOI
  15. 10.1016/0016-5085(89)91641-7 · doi:10.1016/0016-5085(89)91641-7
  16. 10.1055/s-2008-1040724 · DOI · Paper page
  17. 10.1038/ajg.2015.283 · DOI · Paper page
  18. Lewis JH, 1988, Methotrexate‐induced chronic liver injury: guidelines for detection and prevention. The ACG Committee on FDA‐related matters. American College of Gastroenterology, Am. J. Gastroenterol., 83, 1337
  19. 10.1016/S0140-6736(05)74872-8 · DOI
  20. 10.1016/0046-8177(90)90076-H · DOI · Paper page
  21. Kleiner DE, 1997, Histopathologic changes associated with fialuridine hepatotoxicity, Mod. Pathol., 10, 192
  22. 10.1016/S0168-8278(99)80020-8 · DOI · Paper page
  23. 10.7326/0003-4819-115-4-283 · DOI · Paper page
  24. Finkle HI, 1999, Hepatic mitochondrial toxicity from nucleoside analog therapy, Arch. Pathol. Lab. Med., 123, 189, 10.5858/1999-123-0189-HMTFNA · DOI
  25. 10.1002/hep.1840020513 · DOI · Paper page
  26. 10.1016/0002-9610(67)90308-X · DOI
  27. 10.1007/s13181-010-0047-0 · DOI
  28. 10.1016/S0140-6736(83)91629-X · DOI · Paper page
  29. 10.1111/j.1365-2559.2010.03511.x · DOI · Paper page
  30. 10.1111/1751-2980.12177 · DOI
  31. Buffet C, 1988, Three cases of nodular regenerative hyperplasia of the liver following renal transplantation, Nephrol. Dial. Transplant., 3, 327
  32. 10.1097/01.pas.0000128665.12063.97 · doi:10.1097/01.pas.0000128665.12063.97
  33. Morse CG, 2015, Nonalcoholic steatohepatitis and hepatic fibrosis in HIV‐1‐monoinfected adults with elevated aminotransferase levels on antiretroviral therapy, Clin. Infect. Dis., 60, 1569, 10.1093/cid/civ101 · DOI
  34. 10.1097/00000478-200604000-00012 · DOI · Paper page
  35. 10.1097/00005176-198601000-00008 · doi:10.1097/00005176-198601000-00008
  36. 10.1002/hep.28323 · DOI · Paper page
  37. 10.1016/j.cgh.2014.11.036 · DOI · Paper page
  38. 10.1016/j.gastro.2005.05.006 · DOI · Paper page
  39. 10.1111/j.1365-2036.2006.03117.x · DOI · Paper page
  40. 10.1111/his.12449 · doi:10.1111/his.12449
  41. 10.1016/j.revmed.2012.10.372 · DOI
  42. 10.1093/rheumatology/kes397 · DOI
  43. 10.1016/j.cgh.2012.12.025 · DOI · Paper page
  44. 10.1007/s12185-013-1275-2 · DOI
  45. 10.1002/1097-0142(20010715)92:2<406::AID-CNCR1336>3.0.CO;2-U · DOI · Paper page
  46. 10.1016/j.leukres.2011.01.025 · DOI
  47. 10.1007/s10620-012-2140-5 · DOI
  48. 10.1080/10245330600937929 · doi:10.1080/10245330600937929
  49. 10.1097/MPH.0000000000000337 · doi:10.1097/mph.0000000000000337
  50. 10.3109/15563650.2012.673624 · DOI
  51. 10.1200/JCO.2011.41.0332 · DOI
  52. Irey NS, 1976, Teaching monograph. Tissue reactions to drugs, Am. J. Pathol., 82, 613
  53. 10.1111/j.1365-2036.2007.03330.x · DOI · Paper page
  54. 10.1111/j.1478-3231.2006.01377.x · DOI · Paper page
  55. 10.1111/1751-2980.12184 · doi:10.1111/1751-2980.12184
  56. 10.1007/978-3-642-00663-0_11 · DOI
  57. 10.1002/hep.23696 · DOI · Paper page
  58. 10.1007/s10620-016-4121-6 · DOI

Cited by

Metadata

Authors
Kleiner, D. E.
Affiliations
Laboratory of Pathology National Cancer Institute Bethesda MD USA
Venue
Histopathology
Publisher
Wiley
Published
2016-12-13
Volume
70
Issue
1
Pages
81-93
ISSN
  • 0309-0167
  • 1365-2559
Cited by
52
References
3
Language
en
Funders
  • National Institutes of Health
  • National Cancer Institute

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.